• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗应答者和复发者的丙型肝炎病毒显示出相似的 和 单核苷酸多态性的遗传特征。

Hepatitis C Virus-Infected Responders and Relapsers to Treatment Show Similar Genetic Profiles of and Single Nucleotide Polymorphisms.

机构信息

Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ, Brazil.

出版信息

Biomed Res Int. 2018 May 20;2018:2931486. doi: 10.1155/2018/2931486. eCollection 2018.

DOI:10.1155/2018/2931486
PMID:29888255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5985065/
Abstract

Genotype 1 of hepatitis C virus (HCV) is the most prevalent worldwide. Pegylated-interferon and ribavirin therapy is still used in the developing world but has less efficiency in this genotype. Single nucleotide polymorphisms (SNPs) rs12979860 and rs8099917 (IL28B) and rs1800896, rs1800871, and rs1800872 (IL10) are related to treatment outcome, but previous studies clustered nonresponse and relapse patients. The aim of this study is to analyze the frequency of those SNPs in HCV genotype 1 for response, nonresponse, or relapse. Patients were classified according to treatment outcome. Genomic DNA was extracted by blood samples and SNPs were defined by PCR and sequencing. Data analysis was performed with R project. The frequency of rs12979860 CC was similar among responders (0.48) and relapsers (0.46) and lower among nonresponders (0.18). The same trend was observed for rs8099917 TT. rs12979860 CC showed a protective effect for relapsers compared to nonresponders (OR = 0.25) as it occurs with responders (OR = 0.17). Haplotypes 12979860/C rs8099917/T were associated with protection against the nonresponder phenotype compared to responders (OR = 0.27) or relapsers (OR = 0.37). Frequency of rs12979860 and rs8099917 is different between relapsers and nonresponders, but similar between relapsers and responders.

摘要

丙型肝炎病毒(HCV)基因型 1 是全球最常见的类型。聚乙二醇干扰素和利巴韦林治疗在发展中国家仍在使用,但在这种基因型中效果较差。单核苷酸多态性(SNP)rs12979860 和 rs8099917(IL28B)以及 rs1800896、rs1800871 和 rs1800872(IL10)与治疗结果相关,但以前的研究将无应答和复发患者进行了聚类。本研究旨在分析 HCV 基因型 1 中这些 SNP 的频率与应答、无应答或复发的关系。根据治疗结果对患者进行分类。从血液样本中提取基因组 DNA,通过 PCR 和测序定义 SNP。使用 R 项目进行数据分析。应答者(0.48)和复发者(0.46)中 rs12979860 CC 的频率相似,无应答者(0.18)中 CC 的频率较低。rs8099917 TT 也呈现出相同的趋势。与无应答者相比,rs12979860 CC 对复发者具有保护作用(OR = 0.25),与应答者(OR = 0.17)相同。与应答者(OR = 0.27)或复发者(OR = 0.37)相比,12979860/rs8099917/T 单倍型与对无应答表型的保护作用相关。rs12979860 和 rs8099917 的频率在复发者和无应答者之间不同,但在复发者和应答者之间相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/5985065/4805c2804730/BMRI2018-2931486.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/5985065/4805c2804730/BMRI2018-2931486.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c57/5985065/4805c2804730/BMRI2018-2931486.001.jpg

相似文献

1
Hepatitis C Virus-Infected Responders and Relapsers to Treatment Show Similar Genetic Profiles of and Single Nucleotide Polymorphisms.治疗应答者和复发者的丙型肝炎病毒显示出相似的 和 单核苷酸多态性的遗传特征。
Biomed Res Int. 2018 May 20;2018:2931486. doi: 10.1155/2018/2931486. eCollection 2018.
2
Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.IL28B 和 IL10 多态性分布作为巴基斯坦 HCV 基因型 3 患者治疗反应的遗传预测因子。
Arch Virol. 2018 Apr;163(4):997-1008. doi: 10.1007/s00705-018-3711-3. Epub 2018 Jan 16.
3
Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.IL28B 基因(rs8099917、rs12979860)多态性与巴基斯坦丙型肝炎病毒基因型 3 患者对聚乙二醇干扰素治疗的病毒学应答。
Int J Infect Dis. 2015 Jan;30:91-7. doi: 10.1016/j.ijid.2014.09.021. Epub 2014 Nov 20.
4
Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.IL28B基因变异rs12979860和rs8099917对慢性丙型肝炎4型患者联合治疗病毒学应答的强大预测作用
Liver Int. 2014 Jul;34(6):890-5. doi: 10.1111/liv.12321. Epub 2013 Oct 14.
5
The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.IL28B rs12979860、rs11881222 和 rs8099917 多态性及 IP-10 在埃及 4 型基因型患者治疗反应中的预测价值。
Virology. 2013 Sep;444(1-2):292-300. doi: 10.1016/j.virol.2013.06.025. Epub 2013 Jul 16.
6
Single-nucleotide polymorphisms of IL-10 and IL-28B as predictors of the response of IFN therapy in HCV genotype 4-infected children.IL-10 和 IL-28B 的单核苷酸多态性作为预测 HCV 基因型 4 感染儿童 IFN 治疗反应的指标。
J Pediatr Gastroenterol Nutr. 2013 Aug;57(2):155-60. doi: 10.1097/MPG.0b013e31828febf0.
7
Prevalence of rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.rs4803217单核苷酸多态性的患病率与慢性丙型肝炎的临床病程
World J Gastroenterol. 2017 Jun 7;23(21):3815-3824. doi: 10.3748/wjg.v23.i21.3815.
8
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.单一 IL28B 基因型 SNP rs12979860 测定可预测慢性丙型肝炎基因型 1 病毒患者的治疗反应。
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):931-5. doi: 10.1097/MEG.0b013e328349d0ef.
9
Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients.IL28B 基因多态性可预测埃及丙型肝炎 4 型患者的病毒复发。
J Med Virol. 2016 Mar;88(3):481-6. doi: 10.1002/jmv.24354. Epub 2015 Aug 26.
10
IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.IL28B 多态性决定了接受聚乙二醇干扰素/利巴韦林治疗慢性丙型肝炎 1 型患者的早期病毒动力学和治疗结果。
J Viral Hepat. 2011 Jul;18(7):e325-31. doi: 10.1111/j.1365-2893.2010.01425.x. Epub 2011 Jan 13.

引用本文的文献

1
Impact of IL-10 gene promoter polymorphisms on treatment response in HCV patients: A systematic review, a meta-analysis, and a meta-regression.IL-10 基因启动子多态性对 HCV 患者治疗反应的影响:系统评价、荟萃分析和荟萃回归。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241240705. doi: 10.1177/03946320241240705.
2
HCV treatment outcome depends on SNPs of IFNL3-Gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma.丙型肝炎病毒(HCV)的治疗结果取决于IFNL3基因多态性(rs12979860)的单核苷酸多态性(SNPs)以及肝实质的肝硬化改变。
Heliyon. 2023 Oct 19;9(11):e21194. doi: 10.1016/j.heliyon.2023.e21194. eCollection 2023 Nov.
3

本文引用的文献

1
Interleukin-10.rs1800896 and Interleukin-18.rs1946518 gene polymorphisms could not predict the outcome of hepatitis C virus infection in Egyptian patients treated with pegylated interferon plus ribavirin.白细胞介素-10基因rs1800896多态性和白细胞介素-18基因rs1946518多态性无法预测接受聚乙二醇干扰素联合利巴韦林治疗的埃及丙型肝炎病毒感染患者的治疗结果。
Arch Virol. 2016 Sep;161(9):2473-80. doi: 10.1007/s00705-016-2948-y. Epub 2016 Jun 28.
2
Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients.丙型肝炎病毒1型与白细胞介素-6及肿瘤坏死因子-α基因多态性对巴西丙型肝炎病毒感染患者促炎细胞因子血清水平的联合影响
Hum Immunol. 2014 Nov;75(11):1075-83. doi: 10.1016/j.humimm.2014.08.198. Epub 2014 Sep 3.
3
Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients.
慢性丙型肝炎患者中IL28B/TLR4基因变异与接受或未接受直接抗病毒药物(DAA)治疗的肝细胞癌发生之间的相关性。
Genes Dis. 2019 May 27;7(3):392-400. doi: 10.1016/j.gendis.2019.05.004. eCollection 2020 Sep.
Global distribution and prevalence of hepatitis C virus genotypes.丙型肝炎病毒基因型的全球分布与流行情况
Hepatology. 2015 Jan;61(1):77-87. doi: 10.1002/hep.27259. Epub 2014 Jul 28.
4
IFN-λ4: the paradoxical new member of the interferon lambda family.IFN-λ4:干扰素λ家族中矛盾的新成员。
J Interferon Cytokine Res. 2014 Nov;34(11):829-38. doi: 10.1089/jir.2013.0136. Epub 2014 Apr 30.
5
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.IFNL3 多态性可预测慢性丙型肝炎基因型 2/3 感染的治疗反应。
J Hepatol. 2014 Aug;61(2):235-41. doi: 10.1016/j.jhep.2014.03.039. Epub 2014 Apr 24.
6
Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals.IL28B基因分型在伊朗慢性丙型肝炎患者和健康个体中的分布
Hepat Mon. 2012 Dec;12(12):e8387. doi: 10.5812/hepatmon.8387. Epub 2012 Dec 22.
7
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.IFNL3(IL28B)上游的一种变体创造了一个新的干扰素基因 IFNL4,与丙型肝炎病毒清除能力受损有关。
Nat Genet. 2013 Feb;45(2):164-71. doi: 10.1038/ng.2521. Epub 2013 Jan 6.
8
A straightforward genotyping of the relevant IL28B SNPs for the prediction of hepatitis C treatment outcome.直接进行相关 IL28B SNPs 的基因分型,以预测丙型肝炎治疗效果。
J Virol Methods. 2012 Sep;184(1-2):93-7. doi: 10.1016/j.jviromet.2012.05.024. Epub 2012 Jun 1.
9
Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C.血清白细胞介素(IL)-10和IL-12水平以及IL28B基因多态性:慢性丙型肝炎治疗失败的治疗前预测
Antivir Ther. 2011;16(7):1073-80. doi: 10.3851/IMP1869.
10
Polymorphism of tumor necrosis factor-α and interleukin-10 gene promoter region in chronic hepatitis C virus patients and their effect on pegylated interferon-α therapy response.慢性丙型肝炎病毒患者肿瘤坏死因子-α和白细胞介素-10 基因启动子区域的多态性及其对聚乙二醇干扰素-α治疗反应的影响。
Hum Immunol. 2011 Oct;72(10):935-9. doi: 10.1016/j.humimm.2011.06.008. Epub 2011 Jul 1.